AGEN.NASDAQAgenus INC

Form 4: Agenus Inc. Director Jennifer Buell Acquires Shares as Part of Salary Compensation

Sentiment:

SEC Form 4


Jennifer Buell, a director at Agenus Inc., acquired 409 shares of common stock as part of her salary compensation, while disposing of 15,646 shares.

Summary

  • On March 7, 2025, Jennifer Buell, a director at Agenus Inc., acquired 409 shares of Agenus Inc. common stock at a price of $2.35 per share.
  • This acquisition was part of her salary compensation, paid in stock in lieu of cash, as approved by the Agenus Inc. Compensation Committee.
  • The shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested upon issuance.
  • She also disposed of 15,646 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The stock compensation plan aligns director interests with shareholders, which is generally viewed favorably. The disposal of 15,646 shares is a negative but is not explained.

Positives

  • The arrangement to pay a portion of the director's salary in stock aligns her interests with those of the shareholders.
  • The shares are fully vested upon issuance.

Management Comments

  • At her request and with the approval of the Agenus Inc. Compensation Committee, a portion of Jennifer Buell's salary is being paid in stock, in lieu of cash.

Industry Context

This type of stock-based compensation is common in the biotech industry to conserve cash and align executive incentives with shareholder value.

Comparison to Industry Standards

  • Stock-based compensation is a common practice among publicly traded companies, especially in the biotech sector.
  • Companies like Amgen, Gilead Sciences, and Biogen also utilize stock options and restricted stock units as part of their executive compensation packages.
  • The specific amount and vesting schedules vary depending on the company's size, performance, and compensation philosophy.

Stakeholder Impact

  • Shareholders may view the stock-based compensation positively as it aligns the director's interests with the company's performance.
  • Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

DateDescription
03/07/2025Date of transaction: Jennifer Buell acquired 409 shares and disposed of 15,646 shares of Agenus Inc. common stock as part of her salary compensation.
03/24/2025Date of filing: Form 4 filing date.

Keywords

Agenus Inc., Jennifer Buell, Director, Stock Acquisition, Salary Compensation, Equity Incentive Plan, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.